Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 5 minute read Technology Industry News Duolingo raises outlook as AI subscriptions fuel a blowout quarter — investors weigh upside against rising competition See how AI-powered tiers lifted Duolingo’s Q2 and 2025 outlook — and what investors should watch next on margins, ARPU, and competition. byPallavi MadhirajuAugust 9, 2025